Jennifer E Collins, Tiantian Jiang, Jin Woo Lee, Karen Wendt, Flore Nardella, Jin Jeon, Raphaella Paes, Natalia Mojica Santos, Frances Rocamora, Maya Chang, Samuel Schaefer, Robert H Cichewicz, Elizabeth A Winzeler, Debopam Chakrabarti
Our previous work identified a series of 12 xanthoquinodin analogues and 2 emodin-dianthrones with broad-spectrum activities against Trichomonas vaginalis , Mycoplasma genitalium , Cryptosporidium parvum , and Plasmodium falciparum . Analyses conducted in this study revealed that the most active analogue, xanthoquinodin A1, also inhibits Toxoplasma gondii tachyzoites and the liver stage of Plasmodium berghei , with no cross-resistance to the known antimalarial targets PfACS, PfCARL, PfPI4K, or DHODH. In Plasmodium , inhibition occurs prior to multinucleation and induces parasite death following 12 h of compound exposure...
May 29, 2024: ACS Infectious Diseases